The U.S. Food and Drug Administration recently took a small but important step in tobacco product regulation. The agency started the process to bring e-cigarettes, cigars, dissolvable tobacco products, and hookah under its regulatory authority. When the Family Smoking Prevention and Tobacco Control Act became law in 2009, the FDA was only required to regulate cigarettes, smokeless tobacco, and roll-your-own tobacco.
A number of provisions in Affordable Care Act (ACA) promote investments in public health and transformative changes to the health insurance system. The law also prescribes modifications to the health care delivery system that have the potential to make significant and lasting impact on how our country supports new strategies to improve population health outcomes.
Tobacco has dominated headlines lately. On Wednesday, CVS pharmacy announced that it will stop selling tobacco products by October. Some localities, such as Boston and San Francisco, already prohibit the sale of tobacco products in pharmacies.
Leading national public health advocates filed a Citizen Petition on April 12, 2013, urging the U.S. Food and Drug Administration (FDA) to exercise its regulatory power, and to protect America’s health by prohibiting menthol as a characterizing flavoring in cigarettes. The historic menthol petition was delivered to FDA offices by the Tobacco Control Legal Consortium on behalf of 19 public health organizations.